Abstract

Background Prostaglandin E2 plays a crucial role in inflammation, including pain, fever and tumorigenesis. Inflammatory cells, fibroblasts and epithelium are the main source of PGE2 throughout an immune response. There are four known receptors for PGE2, E type prostanoid receptors 1–4 (EP1,2,3,4). According to recent reports, the EP4 receptor seems to be a potential target of therapeutic treatment for attenuating inflammation as well as increased endothelial permeability.

Highlights

  • Prostaglandin E2 plays a crucial role in inflammation, including pain, fever and tumorigenesis

  • The pulmonary microvascular endothelial cells express the PGE2 receptor EP4, which was shown by flow cytometry and Western blotting

  • EP4 receptor protein expression was down-regulated to less than 40% by using the siRNA transfection approach

Read more

Summary

Open Access

The role of PGE2 EP4 receptors in the regulation of endothelial barrier function. From 18th Scientific Symposium of the Austrian Pharmacological Society (APHAR).

Background
Methods
Results
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call